Background-Cardiovascular
A pproximately 20 million Americans have type 2 diabetes mellitus, a disease associated with hypertension and increased risk of cardiovascular disease (CVD). This combination of metabolic abnormalities is the leading cause of morbidity and mortality in industrialized countries. 1 Several studies indicate that in poorly controlled diabetes mellitus, altered insulin signaling and/or hyperglycemia promote unbalanced cholesterol metabolism, which favors oxidized lowdensity lipoprotein (oxLDL) cholesterol retention in the vascular wall. 2 However, the effects of intensive glucose lowering on macrovascular complications in this population are unpredictable and may result in increased mortality. 3 Therefore, identification of glucose-independent factors that modulate macrophage cholesterol deposition and vascular infiltration is critical to understanding the development of CVD in diabetics.
Clinical Perspective on p 698
Vitamin D deficiency is a largely unacknowledged epidemic associated with CVD. Approximately 1 billion people worldwide have low levels of 25-hydroxyvitamin D [25(OH)D; Ͻ80 nmol/L], the principal circulating storage form of vitamin D, and more than half of middle-aged vitamin D-deficient patients develop CVD. 4, 5 In hypertensive patients, low serum vitamin D levels increase the risk of CVD by 60%. 6 In women with type 2 diabetes mellitus, the prevalence of vitamin D deficiency is a third higher than that of control subjects, and low vitamin D levels nearly double the risk of developing CVD compared with diabetic patients with normal vitamin D levels. 7, 8 Similarly, in diabetic patients with mild renal failure, low vitamin D levels increase the relative risk of CVD compared with their vitamin D-sufficient counterparts. 9 Finally, intervention with 1,25-dihydroxyvitamin D 3 [1, 25(OH) 2 D 3 ], the active form of vitamin D, or paricalcitol [a less calcemic 1,25(OH) 2 D analog] decreased cardiovascular mortality in patients with end-stage renal disease, suggesting favorable outcomes from normal vitamin D status in attenuating atherosclerosis. 10 Therefore, understanding the mechanism of the accelerated atherosclerosis induced by vitamin D deficiency may be crucial for treating the epidemic of CVD in diabetics.
Increased proinflammatory cytokines in the vessel wall contribute to immune cell recruitment and modified LDL cholesterol deposition by increasing scavenger receptor expression and cholesteryl ester synthesis and by decreasing cholesterol efflux. 11 Active vitamin D metabolites [1, 25(OH) 2 D 3 or its analogs] promote monocyte/macrophage differentiation and diminish proinflammatory cytokine release by immune mononuclear cells in diabetics, suggesting that 1,25(OH) 2 D 3 signaling may regulate monocyte vascular infiltration and macrophage cholesterol retention in the vessel wall in these patients. 12, 13 Initial studies exploring the influence of 1,25(OH) 2 D 3 on macrophage cholesterol metabolism are contradictory. In human promyelocytic leukemic (HL-60) and monocytic (THP-1) cell lines, 1,25(OH) 2 D 3 decreased scavenger receptor A-1 (SR-A1) expression and acetylated LDL (AcLDL) binding. 14, 15 In contrast, in normal subjects, 1,25(OH) 2 D 3 increased cholesteryl ester formation stimulated by AcLDL, but only under conditions of lipid deprivation. 16 The aim of our study was to determine whether vitamin D deficiency contributes to the increase in macrophage-mediated cholesterol deposition seen in patients with diabetes mellitus and to investigate the effects of 1,25(OH) 2 D 3 on macrophage cholesterol deposition in diabetics and nondiabetic matched controls.
Methods

Population
Our study population included 76 obese, hypertensive adult subjects with type 2 diabetes mellitus on medications with an age of 55Ϯ2 years, body mass index of 32Ϯ1.0 kg/m 2 Table) . Subjects were recruited from the outpatient clinic at Barnes-Jewish Hospital, St Louis (Mo). Participation was voluntary, and each subject provided written informed supplemented media were cultured in high-glucose (450 mg/dL) (routine culture conditions used in this study) and normal-glucose (100 mg/dL) conditions for 7 days before cholesterol homeostasis and CD36 expression were measured. In these glucose conditions and after stimulation with oxLDL for 6 hours, macrophages were cell sorted by staining with phycoerythrin-labeled anti-CD11b and FITClabeled anti-CD14 (e-Biosciences, San Diego, Calif). They were then evaluated for membrane CD36 expression by use of a primary anti-CD36 and a secondary IgM CD36 biotin-labeled antibody (BD Bioscience, San Jose, Calif). FACScan flow cytometry was performed in 20 000 cells.
Mouse Peritoneal Macrophages
Mouse peritoneal macrophages from CD36 Ϫ/Ϫ , SR-A1 Ϫ/Ϫ , and wildtype mice (nϭ12 per each group) were isolated 3 days after intraperitoneal injection of 4% thioglycollate solution and cultured in vitamin D-deficient or 1,25(OH) 2 D 3 -supplemented media (see the online-only Data Supplement). 17 Cholesterol uptake was performed after 6 hours of stimulation with modified cholesterol in mouse macrophages cultured for 7 days in vitamin D-deficient or 1,25(OH) 2 D 3 -supplemented media. Foam cell formation in vivo was determined by measuring total cholesterol and triglycerides in peritoneal macrophages 4 hours after isolation from LDR Ϫ/Ϫ mice fed a vitamin D-deficient (nϭ5) or -sufficient (nϭ5) Western diet for 10 weeks (Harlan, TD 07019). This methodology is also described in the online-only Data Supplement.
Macrophage Cholesterol Homeostasis
Foam cell formation (Oil Red O stain), cholesteryl ester formation, and cholesterol uptake, binding, and efflux were assessed in macrophages after stimulation with oxLDL or AcLDL from same subjects' monocytes cultured in vitamin D-deficient or 1,25(OH) 2 D 3 -supplemented media for 7 days. A detailed description is presented in the online-only Data Supplement.
Plasmids and siRNA
Macrophages obtained from diabetic subjects were cultured for 7 days in vitamin D-deficient or 1,25(OH) 2 D 3 -supplemented media and then infected with lentivirus containing either peroxisome proliferated-activated receptor-␥ (PPAR␥)-siRNA, vitamin D receptor (VDR)-siRNA hairpin, or control siRNA for 48 hours. Protein, mRNA, and cholesterol uptake was determined 48 hours after recovering from viral infection. Descriptions of lentivirus generation are included in the online-only Data Supplement.
Gene Expression, Western Blot Analysis, and JNK Activity
Quantitative reverse-transcription polymerase chain reaction analyses were performed by Sybergreen methodologies. Results were normalized to the housekeeping gene L32. Western blot analyses from macrophage protein extracts were normalized to ␤-actin expression. Phosphorylated AKT and AKT were determined in 12-hour serum-starved macrophages before or after insulin incubation (100 nmol/L). A detailed description is included in the online-only Data Supplement. JNKp also was determined by a cell-based ELISA kit (SA Bioscience).
Statistical Analysis
Experiments were carried out with duplicate or triplicate samples. All data are expressed as meanϮSEM for continuous variables and as ratios for categorical data. Gaussian distribution of continuous variables was verified by Kolmogorov-Smirnov distance. Statistical significance of differences was calculated with the paired t test for parametric data involving 2 groups and ANOVA for parametric data with Tukey test for multiple groups. Two-way ANOVA was performed to test the main effects of each factor and to test for interaction between variables. A 2 test was used for multiple group analysis for categorical variables. Differences were considered statistically significant at PՅ0.05.
Results
Population
In group A, we studied 76 obese adult subjects, primarily black women, with type 2 diabetes mellitus and a concurrent diagnosis of hypertension (80%). Twenty-nine percent of patients were on oral hypoglycemics and long-acting insulin; the remainder took oral medications only. All groups were similar with respect to age, gender, total cholesterol, lipid medications, and tobacco use. Control groups B and C were similar to group A with regard to body mass index, ethnicity, cholesterol levels, and lipid medications, and group C had a lower hemoglobin A 1C and better blood pressure control compared with groups A and B. Control groups D and E had significantly lower body mass index and more ethnic diversity than all other groups. Groups D and E had lower systolic blood pressure compared with groups A and B. All parametric variables tested were normally distributed (the Table) .
1,25(OH) 2 D 3 Prevents Foam Cell Formation
In obese diabetics (group A), macrophages cultured in vitamin D-deficient media exhibited a significant increase in foam cell formation induced by oxLDL and AcLDL compared with macrophages cultured in 1,25(OH) 2 D 3 -supplemented conditions (see arrows in Figure 1A ). In group A, 1,25(OH) 2 D 3 -treated macrophages exposed to AcLDL or oxLDL had almost 50% less cholesteryl ester formation than macrophages maintained on vitamin D-deficient media (PϽ0.01 for both; Figure 1B ). However, in macrophages obtained from nondiabetic controls (group C), AcLDL-or oxLDL-induced cholesteryl ester formation was reduced by 1,25(OH) 2 
1,25(OH) 2 D 3 Decreases Macrophage Cholesterol Uptake
To investigate the mechanism underlying the reduction of foam cell formation induced by vitamin D in diabetics, we assessed cholesterol uptake and efflux in macrophages cultured in either vitamin D-deficient or 1,25(OH) 2 D 3 -supplemented media. Confocal microscopy after fluorescence-labeled 1,1Јdioctadecyl-3,3,3Ј,3Ј-tetramethylindocarbocyanine-labeled (Dil)-oxLDL or Dil-AcLDL stimulation showed that diabetes-derived macrophages (group A) cultured in 1,25(OH) 2 D 3 -supplemented media had decreased oxLDL and AcLDL cholesterol uptake both qualitatively and quantitatively by 40% to 50%, respectively, compared with macrophages cultured in vitamin D-deficient media (PϽ0.01 for both; Figure 2A and 2B). Of note, macrophages from a subgroup of multiple patients from group A that were cultured in 1,25(OH) 2 Ϫ8 mol/L also suppressed macrophage cholesterol binding induced by DiloxLDL or Dil-AcLDL by Ϸ20% (PϽ0.03 for both conditions; Figure 2C and 2D).
In human macrophages, high glucose upregulates and HMG-CoA reductase inhibitors downregulate cholesterol uptake of oxLDL and scavenger receptor expression of CD36. 18, 19 In diabetic patients (group A), 1,25(OH) 2 D 3 suppression of oxLDL cholesterol uptake was independent of the glucose conditions (Pϭ0.2). 1,25(OH) 2 D 3 suppresses oxLDL cholesterol uptake by 30% and 40% in macrophages cultured in high-and low-glucose conditions, respectively, compared with macrophages cultured in vitamin D-deficient media Figure 3F ) and AcLDL ( Figure 3G ) compared with macrophages on vitamin D-deficient media (PϽ0.03 and PϽ0.001, respectively). However, the effect of vitamin D deficiency on cholesterol uptake was blunted by the absence of CD36 or SR-A1 in macrophages ( Figure 3F and 3G) . These results suggest that 1,25(OH) 2 D 3 suppression of oxLDL and AcLDL cholesterol uptake is at least partially mediated by CD36 and SR-A1.
1,25(OH) 2 D 3 Suppression of JNKp Prevents Foam Cell Formation
Stress-related JNK is highly activated in human atherosclerotic plaques and is known to mediate CD36-and SR-A1-dependent foam cell formation in mice. 21, 22 OxLDL activates several mitogen-activated protein kinases, including extracellular signal-regulated kinases, JNK, and p38 mitogen-activated protein kinase, but the role of these pathways in vitamin D regulation of oxLDL or AcLDL uptake is unknown. 21, 23 In vitamin D-deficient diabetics (group A), macrophages cultured in 1,25(OH) 2 D 3 -supplemented media have decreased phosphorylation of JNK1, JNK2, and JNK3 before and after oxLDL or AcLDL stimulation. However, no changes in activation of p38 or extracellular signal-regulated kinase-1 phosphorylation were found in these subjects ( Figure 4A and 4B). In this population, JNKp analysis by ELISA confirmed that macrophages cultured in 1,25(OH) 2 D 3 -supplemented media have 50% lower JNKp levels after either oxLDL or AcLDL stimulation compared with macrophages cultured in vitamin D-deficient media (PϽ0.002 and PϽ0.03, respectively; Figure 4C and 4D). No change in activation of mitogen-activated protein kinase family members was present in nondiabetic controls (group C; Figure VC and VD of the online-only Data Supplement). In macrophages from diabetics (group A), the suppressive effects of JNK inhibition on cholesterol uptake induced by oxLDL or AcLDL were dependent on vitamin D status (PϽ0.01 for both). In macrophages cultured in vitamin D-deficient media, incubation with JNKp inhibitor (SP600125) decreased cholesterol uptake stimulated by oxLDL ( Figure 4E ) and AcLDL ( Figure  4F ) by 50% compared with vitamin D-deficient macrophages not exposed to the JNK inhibitor (PϽ0.03 and PϽ0.01, respectively). No additional JNKp downregulation (data not shown) or cholesterol uptake was observed after SP600125 was added to macrophages cultured in 1,25(OH) 2 D 3 -supplemented media ( Figure 4E and 4F) . These data suggest that vitamin D downregulation of JNKp is a unifying signaling pathway that suppresses oxLDL and AcLDL cholesterol uptake in diabetic patients.
1,25(OH) 2 D 3 Downregulation of JNKp Suppresses Macrophage oxLDL Cholesterol Uptake via PPAR␥
PPAR␥ is expressed in foam cells of human atherosclerotic lesions. 24 PPAR␥ can be activated by oxLDL and controls macrophage CD36 expression. 20 In diabetics (group A), macrophages cultured in 1,25(OH) 2 D 3 -supplemented media had significantly less PPAR␥ protein expression after oxLDL stimulation compared with macrophages cultured in vitamin D-deficient media. Addition of JNKp inhibitor to vitamin D-deficient or 1,25(OH) 2 D 3 -supplemented media almost abolished oxLDL-stimulated PPAR␥ protein expression compared with macrophages without JNK inhibitor ( Figure 5A ). These data suggest that 1,25(OH) 2 D 3 -mediated downregulation of JNKp suppresses PPAR␥ expression.
In vitamin D-deficient conditions, macrophages from diabetic patients (group A) infected with PPAR␥-siRNA lentivirus had almost totally suppressed PPAR␥ and CD36 expression without altering JNKp compared with control siRNA-infected cells ( Figure 5B ). Reduction of PPAR␥ significantly suppressed oxLDL-stimulated cholesterol uptake induced by vitamin D deficiency (PϽ0.01; Figure 5C ). However, no interaction between PPAR␥ inhibition and vitamin D status was identified (Pϭ0.3). These data suggest that 1,25(OH) 2 D 3 -mediated downregulation of JNKp reduces macrophage PPAR␥ and CD36 expression and suppresses oxLDL-stimulated cholesterol uptake in diabetic patients. PPAR␥ downregulation did not alter SR-A1 expression or AcLDL-induced cholesterol uptake (data not shown).
1,25(OH) 2 D 3 Downregulation of ER Stress Prevents Modified LDL-Stimulated Macrophage Cholesterol Uptake and Suppresses SR-A1 and CD36 Expression
Defective macrophage insulin signaling induces the accumulation of misfolded proteins in the ER lumen, causing stress. 2 Persistent ER stress leads to increased SR-A1 expression and JNK activation. 25 In diabetic patients (group A), 1,25(OH) 2 D 3 -supplemented media improved macrophage insulin signaling by increasing insulin-induced AKT phosphorylation ( Figure 5D ). In addition, 1,25(OH) 2 D 3 significantly suppressed the expression of ER stress protein markers (GADD34 and CHOP; Figure 5E ) and reduced CD36 and SR-A1 expression ( Figure 3A through 3E) . Conversely, induction of ER stress with thapsigargin in 1,25(OH) 2 D 3 -treated macrophages increased SR-A1, CD36, PPAR␥, GAD34, and CHOP protein expression and promoted JNK activation compared with macrophages cultured in 1,25(OH) 2 D 3 -supplemented media without thapsigargin (Figure 5F ). Thapsigargin-induced ER stress blunted the 1,25(OH) 2 D 3 suppression of oxLDL-and AcLDL-induced cholesterol uptake compared with macrophages cultured in 1,25(OH) 2 D 3 -supplemented media without thapsigargin (PϽ0.03 and PϽ0.01, respectively; Figure 5G and 5H). By improving insulin signaling and ER stress in macrophages from diabetic patients, 1,25(OH) 2 D 3 modulates JNK activity and PPAR␥ expression and suppresses modified LDL cholesterol uptake.
Activation of VDR Signaling Prevents Foam Cell Formation
1,25(OH) 2 D 3 acts mostly through the VDR, a member of the nuclear receptor superfamily of transcriptional regulators, but also through rapid, nongenomic actions on binding to several other proteins near the plasma membrane of target cells. 26 To identify whether the 1,25(OH) 2 D 3 -suppressive effects on cholesterol uptake are VDR dependent, we infected diabetesderived macrophages (group A) cultured in 1,25(OH) 2 D 3 -supplemented media with lentivirus containing either siRNA VDR hairpins or control siRNA. VDR-siRNA-infected macrophages showed an 80% reduction in VDR mRNA and protein levels and a 6-fold reduction in the mRNA levels of a classic VDR target gene, the 24-hydroxylase (CYP24), compared with control siRNA-infected macrophages (PϽ0.001; Figure 6A through 6C).
Confocal microscopy and quantification of cholesterol uptake confirmed that 1,25(OH) 2 D 3 decreased macrophage cholesterol uptake induced by AcLDL and oxLDL by 50% and 60%, respectively, only in macrophages with intact VDR signaling pathways; this response was blunted in macrophages lacking a VDR signaling pathway (PϽ0.001 and PϽ0.02, respectively; Figure 6D and 6E). In addition, 1,25(OH) 2 D 3 downregulated CD36, SR-A1, and PPAR␥ expression, as well as JNKp, in the presence of intact VDR signaling, but these effects were reduced in VDR-siRNAinfected macrophages ( Figure 6F ). These data confirm the importance of the activation of VDR signaling in the regulation of both scavenger receptors and cell signaling pathways involved in macrophage foam cell formation ( Figure 6G ).
Discussion
Despite aggressive lipid-lowering strategies aimed at type 2 diabetics, CVD remains the leading cause of mortality for these individuals. In this study, we demonstrate that activation of vitamin D receptor signaling prevents foam cell formation by reducing modified LDL cholesterol uptake in macrophages from diabetic patients. Through suppression of ER stress and JNK activation, 1,25(OH) 2 D 3 downregulates 2 critical scavenger receptors involved in macrophage cholesterol deposition. Impairment of VDR signaling confirmed acceleration of foam cell formation in diabetics. Taken together, these results suggest that modulation of vitamin D signaling is a potential therapeutic target to prevent vascular disease progression. Macrophage scavenger receptors play a decisive role in transforming macrophages into foam cells. 20 Targeted disruption of the SR-A1 or CD36 in diet-induced insulin-resistant mouse models confirms the importance of both receptors in the development of atherosclerosis. 29 During hyperglycemia and/or an insulin-resistant state, increased scavenger receptor expression promotes foam cell formation and is considered a link between diabetes mellitus and atherosclerosis. 18, 30 Previous studies indicated the importance of 1,25(OH) 2 D 3 downregulation of SR-A1 receptor expression in tissue plasminogen activator-treated THP-1 macrophages. 15 In this study, we provide evidence that 1,25(OH) 2 D 3 activation of VDR de- creases macrophage cholesterol uptake by reducing CD36 and SR-A1 expression in diabetics. Furthermore, deletion of macrophage VDR interrupts 1,25(OH) 2 D 3 downregulation of CD36 and SR-A1 expression and accelerates oxLDL and AcLDL cholesterol uptake. These data suggest that activation of VDR regulates a unifying cell signaling pathway that suppresses both scavenger receptor expression and uptake of modified LDL cholesterol.
Several mechanisms may be involved in the ability of 1,25(OH) 2 D 3 to suppress macrophage cholesterol ester accumulation in diabetics, but JNK is particularly important. JNK is activated by stressors such as oxidative stress, fatty acids, and inflammatory cytokines, which are commonly present in insulin-resistant tissues. 31 In apolipoprotein E-null mice, pharmacological inhibition of JNK activity and genetic JNK2 deficiency decreased atherosclerosis, in part because of the inhibition of CD36-and SR-A1-dependent foam cell formation. 17 ,22 1,25(OH) 2 D 3 modulates JNK signaling activation in response to extracellular stress stimulation. 32 In concert, p38/JNK activation regulates VDR gene expression, further supporting the interaction between this signaling pathway and vitamin D. 33 In this study, we found that 1,25(OH) 2 D 3 is a natural inhibitor of macrophage JNKp in diabetics. 1,25(OH) 2 D 3 downregulation of the JNK pathway suppresses cholesterol uptake by the scavenger receptors CD36 and SR-A1. Furthermore, targeted deletion of VDR interrupts the ability of 1,25(OH) 2 D 3 to inhibit foam cell formation and JNK activation. These data suggest that downregulation of JNK stress signaling by VDR activation is a unifying mechanism for both scavenger receptor-induced foam cell formation and possibly atherogenesis.
PPAR␥ expression is induced in foam cells of human atherosclerotic lesions. 24 PPAR␥ plays a critical role in maintaining macrophage cholesterol homeostasis by positively regulating the expression of genes involved in cholesterol storage and efflux. 2, 19, 34 Previous observations indicate that 1,25(OH) 2 D 3 is capable of repressing PPAR␥ expression in adipocytes. 35 Consistent with this possibility, we find that 1,25(OH) 2 D 3 downregulation of JNK activation suppresses PPAR␥ and CD36 expression, reducing oxLDL-derived cholesterol uptake. Conversely, inhibition of macrophage PPAR␥ expression suppresses oxLDL-derived cholesterol 
